Prevention of pregnancy in cats using aglepristone on days 5 and 6 after mating.
The aim of this study was to test for the efficacy of aglepristone treatment for prevention of early pregnancy in the cat. Eleven cats (Gr. 1) were treated with 10 mg/kg aglepristone on days 5 and 6 after mating, 17 cats (Gr. 2) were used as untreated controls. Blood samples for progesterone (P4) determination were collected from 6 cats of Gr. 1 and 9 cats of Gr. 2, respectively. Ultrasound examination on day 25 revealed no pregnancy in any of the treated cats. In both groups, P4 concentrations increased from day 5 (before treatment) to day 20 (P < 0.01). In Gr. 1, the interval between aglepristone treatment and the subsequent estrus ranged from 5-299 d [18.5 (5.2) d]. Mean interestrus interval was 205 +/- 72 d in Gr. 2. Mean duration of subsequent estrus was not different to duration of estrus before treatment in Gr. 1 and in Gr. 2, respectively. Mean time between treatment and next pregnancy was 56.4 (4.7) d, ranging from 5-325 d. Pregnancy rates after the next estrus following treatment were 64 and 82% after the first and second estrus, respectively. No major treatment-related side effects were observed. In conclusion, treatment was found to be highly effective for prevention of early pregnancy.
Goericke-Pesch
Sandra
S
Clinic for Obstetrics, Gynecology and Andrology of Large and Small Animals, Justus-Liebig University, Giessen, Germany. Sandra.Pesch@vetmed.uni-giessen.de
Georgiev
Plamen
P
Wehrend
Axel
A
D000818:Animals; D002415:Cats; D003281:Contraceptives, Postcoital / Q000009:adverse effects / Q000494:pharmacology*; D003307:Copulation; D004963:Estrenes / Q000009:adverse effects / Q000494:pharmacology*; D004971:Estrus / Q000187:drug effects / Q000502:physiology; D005260:Female; D005298:Fertility / Q000187:drug effects; D011247:Pregnancy; D018873:Pregnancy Rate; D011374:Progesterone / Q000097:blood
D003281:Contraceptives, Postcoital; D004963:Estrenes; C419063:aglepristone; D011374:Progesterone